Literature DB >> 9394117

Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.

D H Overstreet1, R A McArthur, A H Rezvani, C Post.   

Abstract

The present studies sought to elucidate the role of 5-HT2A receptor antagonists in suppressing alcohol intake by comparing the effects of amperozide and FG 5974 on alcohol, food, and water intake in strains of alcohol-preferring rats: P, Alko Alcohol (AA), and Fawn-Hooded (FH). Both amperozide and FG 5974 have 5-HT2A receptor antagonist properties, but FG 5974 also shows presynaptic 5-HT1A receptor agonist activity. After establishment of stable baselines for intake measures in a two-bottle continuous access paradigm, rats (n = 10) were injected with 1 of 5 doses (0, 2.5, 5.0, and 10.0 mg/kg, sc) of amperozide or FG 5974 at weekly intervals. Amperozide dose-dependently reduced alcohol intake, total fluid intake, and alcohol preference in all three strains under continuous access conditions, whereas FG 5974 was less effective. Food intake was also suppressed by amperozide at higher doses, whereas it was increased by FG 5974. Amperozide also dose-dependently reduced alcohol intake when it was available for only 1 hr/day, but FG 5974 tended to increase it. After oral administration, amperozide was also more effective than FG 5974 in reducing alcohol intake. Despite these differences in efficacy in suppressing alcohol intake, both compounds produced taste aversion to a novel saccharin solution. These complex findings suggest that biochemical properties other than 5-HT2A receptor antagonism (e.g., 5-HT1A receptor agonism) may be involved in the effects of amperozide and FG 5974 on alcohol intake and other consummatory behaviors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9394117

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  19 in total

1.  Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatment.

Authors:  Feng Chen; Amir H Rezvani; Andrew J Lawrence
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

2.  Electroacupuncture reduces voluntary alcohol intake in alcohol-preferring rats via an opiate-sensitive mechanism.

Authors:  David H Overstreet; Cai-Lian Cui; Yao-Ying Ma; Chang-Yong Guo; Ji-Sheng Han; Scott E Lukas; David Y-W Lee
Journal:  Neurochem Res       Date:  2008-07-17       Impact factor: 3.996

Review 3.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 4.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

5.  Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats.

Authors:  Darin J Knapp; David H Overstreet; Mae Huang; Tiffany A Wills; Buddy A Whitman; Robert A Angel; Sarah E Sinnett; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

6.  Brucine suppresses ethanol intake and preference in alcohol-preferring Fawn-Hooded rats.

Authors:  Yu-Ling Li; Qing Liu; Qi Gong; Jun-Xu Li; Shou-Peng Wei; Yan-Ting Wang; Hui Liang; Min Zhang; Li Jing; Zheng Yong; Andrew J Lawrence; Jian-Hui Liang
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

Review 7.  Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism.

Authors:  Roberto Ciccocioppo; Daina Economidou; Andrea Cippitelli; Marino Cucculelli; Massimo Ubaldi; Laura Soverchia; Anbarasu Lourdusamy; Maurizio Massi
Journal:  Addict Biol       Date:  2006-09       Impact factor: 4.280

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 9.  Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.

Authors:  William M Doyon; Alyse M Thomas; Alexey Ostroumov; Yu Dong; John A Dani
Journal:  Biochem Pharmacol       Date:  2013-07-19       Impact factor: 5.858

Review 10.  Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Authors:  Bankole A Johnson
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.